FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003454699> ?p ?o ?g. }

• W2003454699 endingPage "129" @default.
• W2003454699 startingPage "119" @default.
• W2003454699 abstract "A novel opioid peptide antagonist analogue, [3H]Dmt-Tic-(2S,3R)betaMePhe-Phe, derived from the potent, delta-receptor selective TIPP tetrapeptide (Tyr-Tic-Phe-Phe) series was synthesized and radiolabeled by catalytic tritiation of its iodinated precursor peptide. The purified radioprobe exhibited a specific activity of 2.15 TBq/mmol (58 Ci/mmol). The novelty of this compound is that it contains structurally modified tyrosine residue (2',6'-dimethyltyrosine, Dmt1) replacing tyrosine (Tyr1) at the N-terminus, and beta-methyl substituted phenylalanine (betaMePhe3) at the third position. As the configuration of betaMePhe3 side-chain might be different due to diastereomerism, and accordingly can alter the biological activity, both unlabeled threo (2S,3R and 2R,3S) diastereomeric analogues were also prepared and included in this study. The affinity and selectivity (delta-opioid versus mu-opioid receptor) were evaluated by radioreceptor binding assays. Agonist or antagonist potencies were determined in [35S]GTPgammaS binding experiments using Chinese Hamster Ovary (CHO) cells selectively expressing delta- or mu-opioid receptors. The equilibrium binding of the radiolabeled peptide derivative [3H]Dmt-Tic-(2S,3R)betaMePhe-Phe to rat brain membranes was saturable and the Scatchard analysis indicated a single binding site with a Kd of 0.3 nM and a Bmax of 127 fmol/mg protein. A study of [3H]Dmt-Tic-(2S,3R)betaMePhe-Phe binding displacement by various receptor-type specific opioid ligands showed the rank order of competitor's potency delta > mu > kappa, suggesting selective labeling of opioid delta-sites. In the functional tests, the (2S,3R) and (2R,3S) peptides exhibited partial agonist behaviour by weakly stimulating regulatory G-proteins in CHO cell membranes transfected with different receptors. Both isomers were quite weak partial agonists at the delta-receptor and reasonable partial agonists at the mu-receptor, with a prevalence of (2S,3R) over (2R,3S) for the mu-receptor. Consistent with these observations both stereomers competitively inhibited the stimulation of [35S]GTPgammaS binding induced by the prototype delta-agonist peptide (pClPhe4)-DPDPE in delta(m) CHO cell membranes, and still the (2S,3R) compound exerted more potent delta-antagonist effect. [3H]Dmt-Tic-(2S,3R)betaMePhe-Phe represents a high affinity new radioligand and also constitute further example of the influence of beta-methyl substitution on the potency and selectivity of TIPP analogues, thus becoming a valuable biochemical and pharmacological tool in opioid research." @default.
• W2003454699 created "2016-06-24" @default.
• W2003454699 creator A5011139745 @default.
• W2003454699 creator A5027880067 @default.
• W2003454699 creator A5064093167 @default.
• W2003454699 creator A5066954927 @default.
• W2003454699 creator A5075876294 @default.
• W2003454699 creator A5079703139 @default.
• W2003454699 date "2007-09-01" @default.
• W2003454699 modified "2023-10-03" @default.
• W2003454699 title "Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles" @default.
• W2003454699 cites W1952295494 @default.
• W2003454699 cites W1975262853 @default.
• W2003454699 cites W1975598246 @default.
• W2003454699 cites W1975804366 @default.
• W2003454699 cites W1977221227 @default.
• W2003454699 cites W1978251406 @default.
• W2003454699 cites W1978674173 @default.
• W2003454699 cites W1984619216 @default.
• W2003454699 cites W1985967865 @default.
• W2003454699 cites W1991125129 @default.
• W2003454699 cites W1991852001 @default.
• W2003454699 cites W1992306383 @default.
• W2003454699 cites W1992348047 @default.
• W2003454699 cites W1993875308 @default.
• W2003454699 cites W2000705781 @default.
• W2003454699 cites W2003777826 @default.
• W2003454699 cites W2014110722 @default.
• W2003454699 cites W2021206227 @default.
• W2003454699 cites W2022120454 @default.
• W2003454699 cites W2024666284 @default.
• W2003454699 cites W2030506713 @default.
• W2003454699 cites W2032643119 @default.
• W2003454699 cites W2035774084 @default.
• W2003454699 cites W2037704673 @default.
• W2003454699 cites W2041155806 @default.
• W2003454699 cites W2041191698 @default.
• W2003454699 cites W2043023167 @default.
• W2003454699 cites W2052115613 @default.
• W2003454699 cites W2059437136 @default.
• W2003454699 cites W2063689181 @default.
• W2003454699 cites W2079172002 @default.
• W2003454699 cites W2083433463 @default.
• W2003454699 cites W2084282289 @default.
• W2003454699 cites W2085156914 @default.
• W2003454699 cites W2087603137 @default.
• W2003454699 cites W2090166325 @default.
• W2003454699 cites W2104168199 @default.
• W2003454699 cites W2106741447 @default.
• W2003454699 cites W2143379226 @default.
• W2003454699 cites W2148208755 @default.
• W2003454699 cites W2152150798 @default.
• W2003454699 cites W2160555837 @default.
• W2003454699 cites W2950649552 @default.
• W2003454699 cites W4231452461 @default.
• W2003454699 cites W4293247451 @default.
• W2003454699 cites W58031344 @default.
• W2003454699 doi "https://doi.org/10.1016/j.brainresbull.2007.05.010" @default.
• W2003454699 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17683797" @default.
• W2003454699 hasPublicationYear "2007" @default.
• W2003454699 type Work @default.
• W2003454699 sameAs 2003454699 @default.
• W2003454699 citedByCount "10" @default.
• W2003454699 countsByYear W20034546992013 @default.
• W2003454699 countsByYear W20034546992014 @default.
• W2003454699 countsByYear W20034546992017 @default.
• W2003454699 countsByYear W20034546992019 @default.
• W2003454699 crossrefType "journal-article" @default.
• W2003454699 hasAuthorship W2003454699A5011139745 @default.
• W2003454699 hasAuthorship W2003454699A5027880067 @default.
• W2003454699 hasAuthorship W2003454699A5064093167 @default.
• W2003454699 hasAuthorship W2003454699A5066954927 @default.
• W2003454699 hasAuthorship W2003454699A5075876294 @default.
• W2003454699 hasAuthorship W2003454699A5079703139 @default.
• W2003454699 hasConcept C141087196 @default.
• W2003454699 hasConcept C14397066 @default.
• W2003454699 hasConcept C170493617 @default.
• W2003454699 hasConcept C175656101 @default.
• W2003454699 hasConcept C185592680 @default.
• W2003454699 hasConcept C2776165026 @default.
• W2003454699 hasConcept C2778938600 @default.
• W2003454699 hasConcept C2779281246 @default.
• W2003454699 hasConcept C2779564779 @default.
• W2003454699 hasConcept C2779809887 @default.
• W2003454699 hasConcept C2779886867 @default.
• W2003454699 hasConcept C2781063702 @default.
• W2003454699 hasConcept C55493867 @default.
• W2003454699 hasConcept C71240020 @default.
• W2003454699 hasConcept C88016717 @default.
• W2003454699 hasConceptScore W2003454699C141087196 @default.
• W2003454699 hasConceptScore W2003454699C14397066 @default.
• W2003454699 hasConceptScore W2003454699C170493617 @default.
• W2003454699 hasConceptScore W2003454699C175656101 @default.
• W2003454699 hasConceptScore W2003454699C185592680 @default.
• W2003454699 hasConceptScore W2003454699C2776165026 @default.
• W2003454699 hasConceptScore W2003454699C2778938600 @default.
• W2003454699 hasConceptScore W2003454699C2779281246 @default.
• W2003454699 hasConceptScore W2003454699C2779564779 @default.

• next